CPG-oligonucleotide Clinical Trials

Paid Clinical Trials > Browse Categories > Medications / Interventions > Cc > CPG-oligonucleotide

CPG-oligonucleotide

All Categories Medications / Interventions » Cc » CPG-oligonucleotide

Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant

Condition: Septicemia
Interventions: Biological: CPG 7909; Drug: Placebo; Biological: J5-OMP Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Patient Accounts| Sponsor Accounts | Paid Cliical Trials | Find Patients | Clinical Trail Jobs | Articles |Privacy Policy | Email Policy | Terms of Use | HIPPA |Contact Us | Sitemap
All information is pulled by the U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. Note: PaidClinicalTrials.org, paidclinicaltrials.org (Aunica Media llc) are resources that provide individuals with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free